Micaela Medrano

Micaela Medrano

Auto-generated profile, based on publicly available information

Micaela Medrano

Centro de Investigación y Desarrollo en Ciencia y Tecnología de Alimentos (CIDCA, CONICET-UNLP-CIC), Calle 47 y 116 La Plata, Buenos Aires CP 1900, Argentina

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Future Foods
Verified
Journal Article
Open access
AMAna Florencia Moretti
Ana Florencia Moretti
MMMaría Candela Moure
María Candela Moure
FQFlorencia Quiñoy
Florencia Quiñoy
FEFiorella Esposito
Fiorella Esposito
NSNicolás Simonelli
Nicolás Simonelli
ÁLÁngela León-Peláez
Ángela León-Peláez

19 August 2010 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
Patricia Ruas-MadiedoPatricia Ruas-Madiedo
Patricia Ruas-Madiedo
MMM. Medrano
M. Medrano
NSNuria Salazar
Nuria Salazar
CRClara De Los Reyes-Gavilan
Clara De Los Reyes-Gavilan
PPP.F. Pérez
P.F. Pérez
Analia G AbrahamAnalia G Abraham
Analia G Abraham
Aims: To evaluate the capability of the exopolysaccharides (EPS) produced by lactobacilli and bifidobacteria from human and dairy origin to antagonize the cytotoxic effect of bacterial toxins. Methods and Results: The cytotoxicity of Bacillus cereus extracellular factors on Caco‐2 colonocytes in the presence/absence of the EPS was determined by measuring the integrity of the tissue monolayer and the damage to the cell membrane (extracellular lactate dehydrogenase activity). Additionally, the protective effect of EPS against the haemolytic activity of the streptolysin‐O was evaluated on rabbit erythrocytes. The EPS produced by Bifidobacterium animalis ssp. lactis A1 and IPLA‐R1, Bifidobacterium longum NB667 and Lactobacillus rhamnosus GG were able to counteract the toxic effect of bacterial toxins on the eukaryotic cells at 1 mg ml−1 EPS concentration. The EPS A1 was the most effective in counteracting the effect of B. cereus toxins on colonocytes, even at lower doses (0·5 mg ml−1), whereas EPS NB667 elicited the highest haemolysis reduction on erythrocytes. Conclusions: The production of EPS by lactobacilli and bifidobacteria could antagonize the toxicity of bacterial pathogens, this effect being EPS and biological marker dependent. Significance and Impact of the Study: This work allows gaining insight about the mechanisms that probiotics could exert to improve the host health.

29 February 2008 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
MMM Medrano
M Medrano

19 April 2011 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
MMMicaela Medrano
Micaela Medrano
SRSilvia M. Racedo
Silvia M. Racedo
IRIvanna S. Rolny
Ivanna S. Rolny
Analia G AbrahamAnalia G Abraham
Analia G Abraham
PPPablo F. Pérez
Pablo F. Pérez

1 December 2013 in Food Microbiology
Verified
Journal Article
Closed access
MHMaria Fernanda Hamet
Maria Fernanda Hamet
ALAlejandra Londero
Alejandra Londero
MMMicaela Medrano
Micaela Medrano
EVElisabeth Vercammen
Elisabeth Vercammen
KHKoenraad Van Hoorde
Koenraad Van Hoorde
Analia G AbrahamAnalia G Abraham
Analia G Abraham

11 March 2016 in Beneficial Microbes
Verified
Journal Article
Closed access
MHM.F. Hamet
M.F. Hamet
MMM. Medrano
M. Medrano
PPP.F. Pérez
P.F. Pérez
Analia G AbrahamAnalia G Abraham
Analia G Abraham
The activity of kefiran, the exopolysaccharide present in kefir grains, was evaluated on intestinal bacterial populations in BALB/c mice. Animals were orally administered with kefiran and Eubacteria, lactobacilli and bifidobacteria populations were monitored in faeces of mice at days 0, 2, 7, 14 and 21. Profiles obtained by Denaturing Gradient Gel Electrophoresis (DGGE) with primers for Eubacteria were compared by principal component analysis and clearly defined clusters, correlating with the time of kefiran consumption, were obtained. Furthermore, profile analysis of PCR products amplified with specific oligonucleotides for bifidobacteria showed an increment in the number of DGGE bands in the groups administered with kefiran. Fluorescent In Situ Hybridisation (FISH) with specific probes for bifidobacteria showed an increment of this population in faeces, in accordance to DGGE results. The bifidobacteria population was also studied on distal colon content after 0, 2 and 7 days of kefiran administration. Analysis of PCR products by DGGE with Eubacteria primers showed an increment in the number and intensity of bands with high GC content of mice administered with kefiran. Sequencing of DGGE bands confirmed that bifidobacteria were one of the bacterial populations modified by kefiran administration. DGGE profiles of PCR amplicons obtained by using Bifidobacterium or Lactobacillus specific primers confirmed that kefiran administration enhances bifidobacteria, however no changes were observed in Lactobacillus populations. The results of the analysis of bifidobacteria populations assessed on different sampling sites in a murine model support the use of this exopolysaccharide as a bifidogenic functional ingredient.